Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PasiAcroKeto
NCT07866846Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jul 2025
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Hemoglobin A1c at 13 months. Started Jul 2025; status: recruiting.
Beyond the preview
Go deeper on NCT07866846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07866846.